Navigation Links
WTN interview: Dr. Jeffrey Grossman, CEO UW Medical Foundation

Editors Note: Dr. Jeffrey Grossman, president and CEO of the University of Wisconsin Medical Foundation and associate dean for clinical affairs for UW Medical School was the kick-off speaker at the Digital Healthcare Conference 2004. In this interview with WTN, Dr. Grossman discusses how advances in technology are creating huge volumes of data but, at the same time a Knowledge Gap betwee......

Full article >>> se.

That represents the probably most dramatic things we do in medicine and is the sort of thing that makes the news in sound bites, but it doesnt represent the bulk of medicine, it is the tip of the iceberg.

WTN: What happens when medical records are combined with medical images, and physicians will have terabytes if not pedabytes of content to synthesize?

Grossman:......

Full article >>> e the barriers to adoption of information technology to medicine today?

Grossman:
There are a bunch of barriers; one of those is the embedded barrier to change in any organization or industry. That is the sense that you are doing well enough right now, and a resistance to change things in an incremental way, for fear of destabilizing what is already going reasonable well.

So......

Full article >>> br> WTN: What is your perspective on recent government efforts to help accelerate deployment of electronic medical records systems?

Grossman:
My personal belief that this is all tied together with the concepts of universal healthcare, which I believe we need, along a with a more organized and cogent payer system. This is certainly part of the problem. But, what I think we are heari......

Full article >>> ns?

Grossman: There is a good argument of best of breed versus integrated solutions. One of the issues is that it is hard to put best of breeds together. The interfaces are terrible, and I think there is too much vaporware and false advertising about integrated systems which simply as not as functional as they have been portrayed to be.

Whats is happening is that even those ......

Full article >>>
'"/>

Source:wistechnology.com By Mike Klein 06/16/04


Related biology technology :

1. Medical College receives $377K to study brain disease
2. Medical College team creates website for tracking flu
3. Medical College receives $1.4M cancer grant
4. Medical technology firm lands $100K federal grant
5. Doyle outlines spending for Medical College, UWM
6. Medical College lands $8.1M grant to detect bird flu, bioterror agents
7. Medical College dedicates $140M research facility
8. Dunn to step down as Medical College dean
9. Medical College team seeks stem cell patent
10. Medical College part of $5M cancer study
11. Medical College secures $9.7M research grant
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/22/2017)... 2017  PrimeVax Immuno-Oncology, Inc. announced today its CEO, ... Annual Biocom Global Life Science Partnering Conference.  The presentation ... at the Torrey Pines Lodge, in San Diego.  ... Biocom who have chosen our company, amongst numerous others, ... investors, and clinical researchers," said Mr. Chen. "In contrast ...
(Date:2/22/2017)... ... February 22, 2017 , ... ProMIS Neurosciences ... treatments for neurodegenerative diseases, today announced it has issued a scientific white paper ... one of a series of commentaries from ProMIS’s scientific team offering insight into ...
(Date:2/22/2017)... , Feb 22, 2017 ... of the "Global Biological Crop Protection (Bio-Pesticide) Market-By Type, By ... (2016-2021)" report to their offering. ... Global Biological Crop Protection Market is forecasted ... The strong growth in biopesticide or biological crop protection market ...
(Date:2/22/2017)... ... February 22, 2017 , ... NDA Partners ... MD former Acting Deputy Director in the FDA CDRH Division of Cardiovascular, Respiratory, ... joined the company as an Expert Consultant. , In Dr. Spyker’s accomplished career, ...
Breaking Biology Technology:
(Date:2/8/2017)... -- Aware, Inc. (NASDAQ: AWRE ), a leading supplier ... its quarter and year ended December 31, 2016. ... million compared to $6.9 million in the same quarter last ... $0.6 million compared to $2.6 million in the fourth quarter ... was $0.5 million, or $0.02 per diluted share, which compares ...
(Date:2/7/2017)... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... at the LEERINK Partners 6th Annual Global Healthcare Conference ... February 15, 2017 at 10 a.m. Eastern Time. ... be accessed at http://wsw.com/webcast/leerink28/zbh .  The webcast will ... Biomet,s Investor Relations website at http://investor.zimmerbiomet.com . ...
(Date:2/2/2017)... Feb. 2, 2017   TapImmune, Inc. ... company specializing in the development of innovative peptide ... of cancer and metastatic disease, announced today it ... manufacturing of a second clinical lot of TPIV ... receptor alpha. The manufactured vaccine product will be ...
Breaking Biology News(10 mins):